Yıl: 2020 Cilt: 62 Sayı: 1 Sayfa Aralığı: 1 - 9 Metin Dili: İngilizce DOI: 10.24953/turkjped.2020.01.001 İndeks Tarihi: 16-06-2021

Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease

Öz:
Kawasaki disease (KD) is the most common cause of childhood coronary artery disease. The incidence of coronary artery lesions (CALs) has declined with the routine use of intravenous immunoglobulin (IVIG) treatment, but there is still considerable risk for resistance to IVIG treatment and development of CALs. The present study was aimed to determine the risk factors in Turkish children with IVIG resistant KD and coronary artery involvement. Clinical, laboratory and echocardiographic data were retrospectively analyzed in 94 Kawasaki patients. IVIG resistant and responsive groups were compared. The IVIG resistant group had a higher rate of CALs compared to the IVIG responsive group (p<0.05). Duration of fever ≥ 9.5 days, C-reactive protein (CRP) ≥ 88 mg/L and Neutrophil/lymphocyte ratio (NLR) ≥1.69 were the best cutoff values for predicting IVIG resistance before treatment. The criteria for at least two of these three predictors were considered to be statistically significant risk factors for detecting IVIG resistance in KD before treatment (76.47% sensitivity, 71.05% specificity and 95% CI were 50.1-93.19% and 59.51-80.89%, respectively). Based on the clinical and laboratory features, we established a new risk-scoring system for predicting IVIG resistance in a cohort of Turkish children with KD. This may be useful for choosing optimal treatment for KD to prevent coronary artery involvement.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1.McCrindle BW, Rowley AH, Newburger JW, et al. American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention. Diagnosis, treatment, and long-term management of Kawasaki disease: A Scientific Statement for Health Professionals from the American Heart Association. Circulation 2017; 135: e927-e999.
  • 2.Hara T, Nakashima Y, Sakai Y, Nishio H, Motomura Y, Yamasaki S. Kawasaki disease: a matter of innate immunity. Clin Exp Immunol 2016; 186: 134-143.
  • 3.Huang YH, Lo MH, Cai XY, Kuo HC. Epigenetic hypomethylation and upregulation of NLRC4 and NLRP12 in Kawasaki disease. Oncotarget 2018; 9: 18939-18948.
  • 4.Chen KYH, Messina N, Germano S, et al. Innate immune responses following Kawasaki disease and toxic shock syndrome. PLoS One 2018: e0191830.
  • 5.Newburger JW, Takahashi M, Burns JC, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1986; 315: 341-347.
  • 6.Ha KS, Jang GY, Lee J, Lee KC, Son CS. Laboratory markers in incomplete Kawasaki disease according to coronary artery outcome. Korean Circ J 2018; 48: 287-295.
  • 7.Ozen S, Bakkaloglu A, Dusunsel R, et al; Turkish Pediatric Vasculitis Study Group Childhood vasculitides in Turkey: a nationwide survey. Clin Rheumatol 2007; 26: 196-200.
  • 8.Kayiran SM, Dindar A, Gurakan B. An evaluation of children with Kawasaki disease in Istanbul: a retrospective follow-up study. Clinics (Sao Paulo) 2010; 65: 1261-1265.
  • 9.Ozdemir H, Ciftçi E, Tapisiz A, et al. Clinical and epidemiological characteristics of children with Kawasaki disease in Turkey. J Trop Pediatr 2010; 56: 260-262.
  • 10.Egami K, Muta H, Ishii M, et al. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr 2006; 149: 237-240.
  • 11.Kobayashi T, Inoue Y, Takeuchi K, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 2006; 113: 2606-2612.
  • 12.Sano T, Kurotobi S, Matsuzaki K, et al. Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr 2007; 166: 131-137.
  • 13.Sleeper LA, Minich LL, McCrindle BM, et al; Pediatric Heart Network Investigators. Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J Pediatr 2011; 158: 831-835.e3.
  • 14.Davies S, Sutton N, Blackstock S, et al. Predicting IVIG resistance in UK Kawasaki disease. Arch Dis Child 2015; 100: 366-368.
  • 15.Arane K, Mendelsohn K, Mimouni M, et al. Japanese scoring systems to predict resistance to intravenous immunoglobulin in Kawasaki disease were unreliable for Caucasian Israeli children. Acta Paediatr 2018; 107: 2179-2184.
  • 16.Yang S, Song R, Zhang J, Li X, Li C. Predictive tool for intravenous immunoglobulin resistance of Kawasaki disease in Beijing. Arch Dis Child 2019; 104: 262-267.
  • 17.Ayusawa M, Sonobe T, Uemura S, et al; Kawasaki Disease Research Committee. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int 2005; 47: 232-234.
  • 18.Sudo D, Monobe Y, Yashiro M, et al. Coronary artery lesions of incomplete Kawasaki disease: a nationwide survey in Japan. Eur J Pediatr 2012; 171: 651-656.
  • 19.Wang Y, Wang W, Gong F, et al. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease. Arthritis Rheum 2013; 65: 805-814.
  • 20.Kurotobi S, Nagai T, Kawakami N, Sano T. Coronary diameter in normal infants, children and patients with Kawasaki disease. Pediatr Int 2002; 44: 1-4.
  • 21.Kibata T, Suzuki Y, Hasegawa S, et al. Coronary artery lesions and the increasing incidence of Kawasaki disease resistant to initial immunoglobulin. Int J Cardiol 2016; 214: 209-215.
  • 22.Xie T, Wang Y, Fu S, et al. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease. Pediatr Rheumatol Online J 2017; 15: 17.
  • 23.Gülhan B, Kesici S, Beken S, et al. Varying clinical features of Turkish Kawasaki disease patients. Turk J Pediatr 2012; 54: 1-6.
  • 24.Chantasiriwan N, Silvilairat S, Makonkawkeyoon K, Pongprot Y, Sittiwangkul R. Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease. Paediatr Int Child Health 2018; 38: 209-212.
  • 25.Soliman WM, Sherif NM, Ghanima IM, El-Badawy MA. Neutrophil to lymphocyte and platelet to lymphocyte ratios in systemic lupus erythematosus: relation with disease activity and lupus nephritis. Reumatol Clin 2018. doi: 10.1016/j.reuma.2018.07.008.
  • 26.Yoon NB, Son C, Um SJ. Role of the neutrophil-lymphocyte count ratio in the differential diagnosis between pulmonary tuberculosis and bacterial community-acquired pneumonia. Ann Lab Med 2013; 33: 105-110.
  • 27.Zahorec R. Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 2001; 102: 5-14.
  • 28.Kawamura Y, Takeshita S, Kanai T, Yoshida Y, Nonoyama S. The combined sefulness of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in predicting intravenous immunoglobulin resistance with Kawasaki disease. J Pediatr 2016; 178: 281-284.e1.
  • 29.Cho HJ, Bak SY, Kim SY, et al. High neutrophil: lymphocyte ratio is associated with refractory Kawasaki disease. Pediatr Int 2017; 59: 669-674.
  • 30.Klinger MHF, Jelkmann W. Role of blood platelets in infection and inflammation. J Interferon Cytokine Res 2002; 22: 913-922.
  • 31.Lim GW, Lee M, Kim HS, Hong YM, Sohn S. Hyponatremia and syndrome of inappropriate antidiuretic hormone secretion in Kawasaki disease. Korean Circ J 2010; 40: 507-513.
APA turkucar s, YILDIZ K, ACARI C, DUNDAR H, Kir M, Unsal E (2020). Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease. , 1 - 9. 10.24953/turkjped.2020.01.001
Chicago turkucar serkan,YILDIZ KAAN,ACARI Ceyhun,DUNDAR Hatice ADIGÜZEL,Kir Mustafa Caglar,Unsal Erbil Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease. (2020): 1 - 9. 10.24953/turkjped.2020.01.001
MLA turkucar serkan,YILDIZ KAAN,ACARI Ceyhun,DUNDAR Hatice ADIGÜZEL,Kir Mustafa Caglar,Unsal Erbil Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease. , 2020, ss.1 - 9. 10.24953/turkjped.2020.01.001
AMA turkucar s,YILDIZ K,ACARI C,DUNDAR H,Kir M,Unsal E Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease. . 2020; 1 - 9. 10.24953/turkjped.2020.01.001
Vancouver turkucar s,YILDIZ K,ACARI C,DUNDAR H,Kir M,Unsal E Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease. . 2020; 1 - 9. 10.24953/turkjped.2020.01.001
IEEE turkucar s,YILDIZ K,ACARI C,DUNDAR H,Kir M,Unsal E "Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease." , ss.1 - 9, 2020. 10.24953/turkjped.2020.01.001
ISNAD turkucar, serkan vd. "Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease". (2020), 1-9. https://doi.org/10.24953/turkjped.2020.01.001
APA turkucar s, YILDIZ K, ACARI C, DUNDAR H, Kir M, Unsal E (2020). Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease. Turkish Journal of Pediatrics, 62(1), 1 - 9. 10.24953/turkjped.2020.01.001
Chicago turkucar serkan,YILDIZ KAAN,ACARI Ceyhun,DUNDAR Hatice ADIGÜZEL,Kir Mustafa Caglar,Unsal Erbil Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease. Turkish Journal of Pediatrics 62, no.1 (2020): 1 - 9. 10.24953/turkjped.2020.01.001
MLA turkucar serkan,YILDIZ KAAN,ACARI Ceyhun,DUNDAR Hatice ADIGÜZEL,Kir Mustafa Caglar,Unsal Erbil Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease. Turkish Journal of Pediatrics, vol.62, no.1, 2020, ss.1 - 9. 10.24953/turkjped.2020.01.001
AMA turkucar s,YILDIZ K,ACARI C,DUNDAR H,Kir M,Unsal E Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease. Turkish Journal of Pediatrics. 2020; 62(1): 1 - 9. 10.24953/turkjped.2020.01.001
Vancouver turkucar s,YILDIZ K,ACARI C,DUNDAR H,Kir M,Unsal E Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease. Turkish Journal of Pediatrics. 2020; 62(1): 1 - 9. 10.24953/turkjped.2020.01.001
IEEE turkucar s,YILDIZ K,ACARI C,DUNDAR H,Kir M,Unsal E "Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease." Turkish Journal of Pediatrics, 62, ss.1 - 9, 2020. 10.24953/turkjped.2020.01.001
ISNAD turkucar, serkan vd. "Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease". Turkish Journal of Pediatrics 62/1 (2020), 1-9. https://doi.org/10.24953/turkjped.2020.01.001